Related Experiment Video
Updated: Jul 11, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Osteoporosis and chronic kidney disease
Anca Gal-Moscovici1, Stuart M Sprague
1Division of Nephrology and Hypertension and Department of Medicine, Evanston Northwestern Healthcare, Northwestern University Feinberg School of Medicine, Evanston, Illinois, USA.
Osteoporosis and chronic kidney disease (CKD) significantly increase fracture risk. Current diagnostic tools fail to adequately identify osteoporosis in CKD patients, necessitating improved approaches for bone health management.
Area of Science:
- Nephrology
- Endocrinology
- Bone Metabolism
Background:
- Osteoporosis (OP) is a prevalent bone disease linked to elevated fracture risk.
- Impaired kidney function causes mineral and bone disturbances, increasing fracture risk, morbidity, and mortality.
- The combined effect of OP and CKD on fracture risk is additive, requiring careful patient management.
Purpose of the Study:
- To review the pathophysiologic processes of osteoporosis and renal osteodystrophy.
- To address limitations of current diagnostic tools for OP in CKD patients.
- To discuss therapeutic strategies for managing bone disease in kidney disease.
Main Methods:
- Literature review focusing on bone pathophysiology in osteoporosis and chronic kidney disease.
- Analysis of diagnostic challenges and limitations in current clinical practice.
- Examination of therapeutic approaches for combined bone disorders.
Main Results:
- Chronic kidney disease-mineral and bone disorder (CKD-MBD) presents complex bone and metabolic changes.
- Standard osteoporosis diagnostic tools are insufficient for CKD patients.
- Inappropriate or delayed therapy can result from diagnostic challenges.
Conclusions:
- Accurate diagnosis and treatment of osteoporosis in kidney disease patients are critical.
- Development of specialized diagnostic tools for CKD-related bone disease is needed.
- Integrated management strategies are essential for improving outcomes in patients with both conditions.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Diabetic Nephropathy
